Related Experiment Video
Updated: May 8, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Midodrine: a novel therapeutic for refractory chylothorax
Douglas Z Liou1, Heather Warren1, Dermot P Maher1
1Cedars-Sinai Medical Center, Los Angeles, CA.
Thoracic duct injury can cause difficult-to-manage chyle leaks. Midodrine, an alpha-1 adrenergic agonist, effectively reduced chyle output in a refractory case, suggesting its potential as a novel therapeutic.
Area of Science:
- Cardiology
- Thoracic Surgery
- Vascular Surgery
Background:
- Thoracic duct injury is a rare but serious complication of neck and chest surgery.
- Uncontrolled chyle leak (chylothorax) poses significant management challenges.
- Limited medical therapies exist for refractory chyle leaks.
Observation:
- A patient presented with high-output chylothorax unresponsive to conventional treatments.
- Aggressive medical and surgical interventions, including thoracic duct ligation and fibrin glue, failed to resolve the chyle leak.
Findings:
- Administration of midodrine, an alpha1-adrenergic agonist, led to a substantial decrease in chyle output.
- Midodrine's mechanism involves vasoconstriction of the lymphatic system, reducing chyle flow.
Implications:
- Midodrine may represent a novel medical therapy for refractory chyle leaks.
- This case suggests a potential new treatment avenue for managing thoracic duct injuries.
- Further research is warranted to explore midodrine's efficacy and safety in larger cohorts.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
